FOLH1 and metastatic malignant neoplasm in the lymph nodes: On [68Ga]Ga-PSMA-11 PET, 19 (38%) patients had PSMA-positive primary/local recurrence, 26 (52%) had PSMA-positive lymph node metastases, and 13 (26%) had PSMA-positive bone metastases.